Cerebrospinal fluid (CSF) is a clear and watery liquid that flows in and around the brain and spinal cord. Its functions ...

Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for ...

Could NfL and GFAP redefine how clinicians track progression in MS? Dr Mark Freedman joins Dr Anne Cross to explain the ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

Q3 2025 Earnings Call Transcript November 24, 2025 BioLineRx Ltd. beats earnings expectations. Reported EPS is $-0.22, ...

Unlock peak brain performance with simple sleep adjustments. Dr Vass, a longevity doctor, reveals how optimizing your sleep ...

New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the ...

Q4 2025 Earnings Call Transcript November 25, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

Supply chains are the glue that holds the global economy together. They’re also a significant source of cyber-related business risk. Attacks on suppliers surged by 431% between 2021 and 2024, and they ...

Gemma Biotherapeutics ("GEMMABio"), a leading global genetic medicines company, announced that its novel gene therapy for spinal muscular atrophy type 1 (SMA1) is cleared for clinical trial by ANVISA, ...

I will now hand the conference call over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, Vince. Thank you, Andrew. Good afternoon, and thank you for joining us ...

Smart threat intel cuts through the noise, helping teams move faster, shrink risk and finally give leaders confidence their ...